Entrepreneur, Healthcare consultant at Recon Strategy, Co-founder Assurance Testing Alliance, Alum of @BCG @Wharton, #Stephanian #Lawrencian. Personal tweets.
Boston
Joined February 2009
- Tweets1.9K
- Following769
- Followers1.3K
- Likes719
Pinned Tweet
My @TEDxBoston talk on LLMs and #ChatGPT uncovers a necessary success factor. youtu.be/5V10R6lcIl4 @TEDTalks @TEDxBeaconSt
This shortcut is worth taking! Think of it as GenAI for spreadsheets. Can provide tremendous leverage to the best analysts, which dramatically improves value.
tryshortcut.ai is live for all
Nikhil Bhojwani retweeted
Biotech analysts studied 229 preclinical asset deals signed between '10–'15 to see which ones reached late stage clinical development & resulted in revenue for licensors h/t @ReconStrategy. Assets without a specified target rarely progressed into the clinic which suggests these programs have l"ow priority or weak preclinical data," they said
That was fun! We talked about what's happening in AI, implications for healthcare, and #ResponsibleAI. Thanks
@BrighamSurgery and @harvardmed for the honor. Here's a link to the talk available online (at least for now).
bwhedtech.media.partners.org…
We welcome @bnikhil as the 2023 Dorothy R. Eisenberg Visiting Professor in Surgery Innovation! Nikhil will be presenting #GrandRounds tomorrow Nov. 1.
Nikhil Bhojwani retweeted
We welcome @bnikhil as the 2023 Dorothy R. Eisenberg Visiting Professor in Surgery Innovation! Nikhil will be presenting #GrandRounds tomorrow Nov. 1.
We only "need a mild downturn" to get inflation back on track in 12-15 months. This is not a Volcker situation and the Fed remains credible. Optimistic data rich presentation by economist Michael Chamberlain of @bofa at #WMIF2023 @MGBInnovation. Risk is promising "low for long."
"We're in the business of failing but occasionally we succeed" @biogen CEO in conversation with @megtirrell at #WMIF2023 talking about drug pricing. "I share @Merck's outrage at the IRA." @MGBInnovation
Safety is a key discussion point for panel on LLMs in healthcare at #WMIF2023. Focus on low risk use cases and use specific use case experts for RHLF @MGBInnovation
Education needs to move to teaching people how to ask the right questions @stephen_wolfram in conversation with @lexfridman at @MITSloan at #imaginationinaction
"I'd prefer an NP or PA using ChatGPT over a doctor not using ChatGPT" says @zakkohane in a superb conversation with @DShaywitz @harvardmed
"60 may be the new 40 but 80 is still 80." @Merck Executive Chairperson Ken Frazier quoting his wife pushing him to think about his life priorities.
"How many summers do you have left?" Powerful message at @statnews #STATsummit.
"Designing cancer studies to approve drugs rather than to learn is a mistake. We're still in the Framingham Study stage of learning about cancer." @DrSidMukherjee @statnews #STATstudy
Pain may have been the graveyard of drug discovery but now we have found the holy grail. @VertexPharma gets the award for the most exciting mixed metaphor at the @statnews summit. #pain #biotech #STATsummit
Pain may have been the graveyard of drug discovery but now we have found the holy grail. @VertexPharma gets the award for the most exciting mixed metaphor at the @statnews summit. #pain #biotech
Nikhil Bhojwani retweeted
Location analysis of Amazon's One Medical (primary care) acquisition by @ReconStrategy. About 2/3 of ONEM's commercial clinics are within 1 mile of a Whole Foods store. "clinics are in 13 of Amazon Care's 23 markets of interest for 2022." h/t @bnikhil reconstrategy.com/2022/07/wh…
"We're the waterboy for the worst team in the worst league," @Jonathan_Bush describing @ZusHealthHQ as a platform. Also Harry Potter and Jiminy Cricket references. No one explains it like he does! #MITplatforms @mit_ide
Incumbents facing a barrage of competition from healthcare platforms. Part of a clear and insightful setup at @mit_ide by @VinceKuraitis and Randall Williams.
The amazing "Disruptive Dozen" gene and cell therapies at #WMIF2022 will transform care. #7 restores the "brain of the gut." Truly transformative stuff #WMIF2022 @MGBInnovation. @US_FDA good to hear that you're looking for new ways to get these to more patients faster.
ALT Photograph of surgeons doing a procedure from the patient's perspective (looking up).
Going public is not the goal. It's just a way of accessing capital. Having constraints on capital can be a good thing for innovation as it forces choice and efficiency/ scale. Full house listening to @MGBInnovation #WMIF2022 panel on the state of biotech investments.
Genomic sequencing of all babies is critical as progressive degenerative diseases have a narrow window for therapeutic interventions. Diagnosing after symptoms is too late. #WMIF2022 @RobertCGreen @adamjshay @MGBInnovation
